Background. Rates of invasive pneumococcal disease (IPD) among indigenous populations remain substantially higher than their non-indigenous counterparts. The goal of this study was to analyze the epidemiology and demographic features of IPD in northwestern Ontario (NWO) among the indigenous and non-indigenous population in the context of recent changes in the provincial pneumococcal vaccination programs.
Methods. Two databases were used to identify cases of IPD in NWO: Thunder Bay Regional Health Sciences Centre and the Thunder Bay District Health Unit. Adult patients with a diagnosis of IPD at the TBRHSC from January 1, 2006 to December 31, 2015 had their medical charts retrospectively reviewed; TBDHU data contained only serotype, age, and gender data. The proportion of non-vaccine serotypes has increased, on average, by 16% per year (P = 0.024, 95% CI: 1.02, 1.32).
Conclusion.
High rates of IPD were found to occur among immunocompromised indigenous adults in NWO. Our findings identify a vulnerable cohort of the population that would benefit from pneumococcal vaccination coverage. The proportion of non-vaccine serotypes causing IPD has increased during the 10-year observation period. Methods. 6,197 S. pneumoniae originated from patients (≥18 years old) seen/ hospitalized in 105 US sites and recovered primarily (78.3%; 4,852/6,197 ) from lower respiratory tract specimens. Identification was performed by biochemical algorithms and/or PCR, and susceptibility (S) testing used broth microdilution. MIC interpretation applied CLSI criteria. The cpsB sequence was obtained by PCR or whole genome sequencing for STs determinations. Multiplex PCR and/or Quellung reactions were also performed, as needed.
Results. All isolates were highly S to levofloxacin (98.7-99.2%), vancomycin (100.0%), and linezolid (100.0%). PCV7 STs showed a reduction in the NS rates for
